Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyExpression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemiaThe isolation of a human Ig V lambda gene from a recombinant library of chromosome 22 and estimation of its copy numberIdentification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with NumbGeneration of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemiaLessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemiaProfile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemiaIntegrative analysis of the melanoma transcriptomeThe first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemiaThe chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcriptIdentification of the human pim-1 gene product as a 33-kilodalton cytoplasmic protein with tyrosine kinase activityThe t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger proteinMassively parallel sequencing: the next big thing in genetic medicineErbB receptors: from oncogenes to targeted cancer therapiesChromosomal rearrangements and microRNAs: a new cancer link with clinical implicationsUbp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signalingAssociation of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11)Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learnedThe Philadelphia chromosome in leukemogenesisChronic myeloid leukemia: reminiscences and dreamsBMI1: A Biomarker of Hematologic MalignanciesUpdate on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinibEmerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other CancersMicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemiaManagement of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors TreatmentOncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesEfficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature ReviewTranslating cancer genomes and transcriptomes for precision oncologyCytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsNext-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?An Overview and Update of Chronic Myeloid Leukemia for Primary Care PhysiciansPatterns of Chromosomal Aberrations in Solid TumorsPhysiology of the read-write genomeGenetics of myeloproliferative neoplasmsClinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challengesKinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitorsRole of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia developmentThe spectrum of adaptive mutations in experimental evolutionDual effect of oxidative stress on leukemia cancer induction and treatmentThe consequences of chromosomal aneuploidy on the transcriptome of cancer cells
P2860
Q21129303-470988FD-51C6-4BF8-84F0-C452BD718D25Q21245701-ABBDEFCE-4B2F-492D-A732-92FAA6F910BBQ24300710-C95FD1B4-A4E5-4123-9849-AE13CB1A7158Q24305261-E18552CD-1759-4862-9F06-BDBA168D33B9Q24596770-E9E11226-2079-49CD-87DE-5ED3DC800B26Q24599829-8E45F552-011D-4C31-A537-743253F2009AQ24607114-E2CD37EB-CFA3-441C-AB78-3E16EBFA5800Q24608060-F391D627-5EA1-4E63-8358-352002435A43Q24613429-C6CF4DFB-3B2D-4A5F-82C6-056792556979Q24615435-69D8394F-0227-4DC9-8497-9EA564E7B6D9Q24632239-D3B0A684-E9D8-48B4-91BD-AB800EA51E0EQ24633137-D00B7307-79EB-4624-BD64-9F59F9184203Q24653648-52607A01-27D0-4526-8D2D-4345BD038505Q24683709-EA6B19F9-3DB6-46BB-83BC-57AE96840E6DQ24683729-99A0DDEE-5657-43CE-A45D-D053F1D5585FQ24685070-CDE7A3FE-8F8F-4D5C-8275-A0E4F4D4E914Q24797667-490F3A79-8856-4549-83FD-633FAE6984DDQ26738514-0559D803-2FF2-4E0F-8FB8-D70276F07F0FQ26745531-2F7DEAE2-C3E8-460F-88D0-DDD219CB45D1Q26748769-05D94932-E8F3-4D22-8F08-C74A7E0BD264Q26750676-A1C30F2A-74AE-4150-B1E0-43336D4E58F1Q26751285-D1FBED64-4BA5-4D32-90AF-949B8D6CBD6EQ26766271-9A3D5033-0D3B-42E9-97FE-EF042EB7523BQ26766288-6DC3E976-ECEC-413E-BCEA-695F72C463D8Q26766299-29F1A02E-E7B4-4F5A-8C39-4337F7D8F842Q26768158-6635ACFC-8211-4669-9B46-4418BC43A8E6Q26775622-F89CC4EA-4207-493E-A309-0CAD90FE9CB2Q26777081-FFFD545E-AA49-46B1-B166-592E9D743B75Q26778929-AC682F77-1B17-4177-BF73-57F9D81C2179Q26781271-6EA169D8-E07B-4869-99B4-B9AD37E224BDQ26782165-0CF35B96-2B85-48DB-9D45-52AB8D22B706Q26786127-201C7428-B24E-4617-99A0-7AD69487534BQ26822420-388AC108-C6CB-4FAD-8331-0530952966CBQ26823651-3C79898A-863F-456D-AAD3-5593F67ACBC1Q26823978-E7471AE0-A3B3-4A87-8F5A-B6AD62421DC7Q26849792-71551F1A-AD49-41B7-9F2B-73B595C1D0E0Q26861674-E2C19F47-73F6-410C-AF08-F3CB39932D05Q26864257-4064CB5A-090C-4739-87B3-CB99FD5AE775Q26866544-FD8CA4A2-D4BF-47C2-BE16-34774C2FDD1FQ26995532-21FC724D-70CA-4615-A097-C8E0F661F5B9
P2860
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
description
1973 nî lūn-bûn
@nan
1973 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Letter: A new consistent chrom ...... uorescence and Giemsa staining
@ast
Letter: A new consistent chrom ...... uorescence and Giemsa staining
@en
type
label
Letter: A new consistent chrom ...... uorescence and Giemsa staining
@ast
Letter: A new consistent chrom ...... uorescence and Giemsa staining
@en
prefLabel
Letter: A new consistent chrom ...... uorescence and Giemsa staining
@ast
Letter: A new consistent chrom ...... uorescence and Giemsa staining
@en
P3181
P356
P1433
P1476
Letter: A new consistent chrom ...... uorescence and Giemsa staining
@en
P2093
P2888
P3181
P356
10.1038/243290A0
P407
P577
1973-06-01T00:00:00Z
P6179
1012018569